Clear Labs, Inc.
San Carlos, CA · Founded 2013 · CIK 0001595806 · Medtech · Private
Automated next-generation sequencing platform with integrated software for infectious disease and oncology analysis
clearlabs.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $116M
- 5 Form D · Dec 2024
- 21 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 32
- 10 granted · 22 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,049,999 | |
| Private capital raised | Form D · SEC | $6,179,911 | |
| Private capital raised | Form D · SEC | $19,337,987 | |
| Private capital raised | Form D · SEC | $59,999,933 | |
| Private capital raised | Form D · SEC | $29,062,615 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 882 | Boundless Corp. | — | $680K |
| 883 | ProTom International, Inc. | — | $1.8M |
| 884 | Fluidic, Inc. | — | $34M |
| 885 | Clear Labs, Inc. | — | $116M |
| 886 | MAGNETIC INSIGHT, INC | — | — |
| 887 | MAUI IMAGING, INC. | — | $23M |
| 888 | TELESECURITY SCIENCES, INC. | — | $3.3M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Sasan AminiDirector · Executive Officer
- Edward FanExecutive Officer
- Ming FangDirector
- Jeff FieldExecutive Officer
- Gaurav GargDirector
- Mahni GhorashiExecutive Officer
- Brian HoganExecutive Officer
- Ramin KhaksarExecutive Officer
- Richard MurdockDirector
- Farzad NaimiDirector · Executive Officer
- Kazutaka OhnoExecutive Officer
- Charlie PiperDirector
- Michael RobachDirector
- Nicolas RoelofsDirector
- Mostafa RonaghiDirector
- Michael TaylorDirector
- Greg YapDirector
Patents
- Systems And Processes For Distinguishing Pathogenic And Non-pathogenic Sequences From Specimensgranted
- Fully Automated Sample Processing Platform From Extraction To Sequencingapplication
- Fully Automated Sample Processing Platform From Extraction To Sequencingapplication
- Automated Priming And Library Loading Deviceapplication
- Automated Nucleic Acid Library Preparation And Sequencing Devicegranted
- Automated Priming And Library Loading Devicegranted
- Automated Priming And Library Loading Deviceapplication
- Automated Priming And Library Loading Deviceapplication
- Automated Priming And Library Loading Devicegranted
- Methods And Kits For Detecting Pathogensapplication
- Systems And Processes For Distinguishing Pathogenic And Non-pathogenic Sequences From Specimensgranted
- Automated Priming And Library Loading Deviceapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.